Milestone Pharmaceuticals Inc. (MIST) › Cash & EquivalentsMilestone Pharmaceuticals Inc. (MIST) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $85.95M2019: $119.82M2020: $72.31M2021: $114.14M2022: $7.64M2023: $13.76M2024: $25.31M2025: $73.05M$73.05M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$73.05M+188.6%2024$25.31M+84.0%2023$13.76M+80.2%2022$7.64M-93.3%2021$114.14M+57.8%2020$72.31M-39.7%2019$119.82M+39.4%2018$85.95M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share